Tag: generic drug approval
Paragraph IV Certification: How Generic Drugs Challenge Patents and Enter the Market
Learn how Paragraph IV certification under the Hatch-Waxman Act allows generic drugs to challenge patents and enter the market early, lowering costs for consumers.
Stability Testing for Generics: FDA Requirements Explained
Learn exactly what the FDA requires for stability testing of generic drugs, from batch testing and storage conditions to common rejection reasons and upcoming 2025 changes that impact approval timelines.